Danika Rothwell

Danika Rothwell is a Managing Associate at Dentons and a member of the firm’s Health Care Practice, based in San Francisco/Oakland, focusing on Health Care Law. She advises clients on a broad range of regulatory and compliance matters, with a focus on health care fraud and abuse, data privacy, and state and federal enforcement risks.

She counsels health care providers, hospital systems, private equity firms and other health care investors on responding to government investigations, structuring transactions, and navigating complex regulatory issues involving the False Claims Act, the Anti-Kickback Statute and HIPAA. Her practice also includes advising on telemedicine, licensure and corporate practice of medicine matters, particularly in connection with multi-state operations and emerging care delivery models.

Prior to joining Dentons, Danika served as a Legal Fellow in the Health Affairs, Privacy, and Data Protection Law Group at the University of California’s Office of General Counsel, where she focused on legal issues related to health care fraud and abuse, clinical research compliance, and data privacy and confidentiality.

Her experience includes assisting hospitals, physicians and medical device manufacturers in responding to government and internal investigations involving the False Claims Act, Drug Enforcement Administration (DEA) compliance and related complex civil litigation; analysing and structuring telemedicine arrangements among hospital systems, practitioners and institutional health care providers, including drafting contracts to deliver essential telemedicine care to providers in medically underserved areas; advising clients on Medicare and Medicaid regulatory issues, including reimbursement, enrolment and programme integrity matters; and serving on regulatory teams advising clients on complex transactions and assisting with due diligence workstreams for regulatory matters.

She has co-authored numerous publications on health care regulatory developments, including on the filed-rate doctrine and FCA claims concerning ACA premium rates, HHS-OIG’s remote patient monitoring report and fraud alert, DOJ’s approach to “but for” causation in FCA kickback cases, state regulation of MSOs, private equity in healthcare, FDA draft guidance for AI-enabled devices, HIPAA oversight and enforcement, and online tracking technologies.

Her practice areas include digital health. She holds a JD from the University of California, Hastings College of the Law (2021) and a Bachelor of Arts (Hons) from Whitman College (2016). She is a member of the American Health Lawyers Association (2019–present) and served as Senior Editor of the Constitutional Law Quarterly (2020–2021).